Fear has seized thousands of Kenyans who have already received the AstraZeneca vaccine and are currently waiting for a second dose, after the report that the vaccine is delaying and they are opting to import one million doses of Johnson and Johnson vaccine and one million of Prizer Vaccines.
According to a report by the health ministry, Africa was expected to receive 75 million AstraZeneca vaccines from India but has only received 12 million only where the expected 2.5-second dose will be delayed.
"Ati ati ya chanjo ya covid-19. Ipo hofu kuwa chanjo 2.5m za AstraZeneca zitachelewa; serikali inaagiza aina ya Johnson & Johnson na Prizer," NTV tweeted.
Kagwe has said that it's not advised to take different vaccines following the fact that he took the AstraZeneca vaccine but said that the Chinese are saying they will start mixing them hence the fact is clear of the effects of mixing different types of vaccines.
Content created and supplied by: Saramwas (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More